MEDI 428-Development of prostaglandin D2 receptor antagonist based on a tetrahydropyridoindole scaffold

被引：0

作者：

Beaulieu, Christian ^{[1
]}

Guay, Daniel ^{[1
]}

Wang, Zhaoyin ^{[1
]}

Leblanc, Yves ^{[1
]}

Roy, Patrick ^{[1
]}

Dufresne, Claude ^{[1
]}

Zamboni, Robert ^{[1
]}

Berthelette, Carl ^{[1
]}

Day, Stephen

Tsou, Nancy N. ^{[2
]}

Denis, Danielle ^{[3
]}

Greig, Gillian ^{[3
]}

Mathieu, Marie-Claude ^{[3
]}

Vigneault, Erika ^{[3
]}

O'Neill, Gary ^{[3
]}

机构：

[1] Merck Frosst Canada Inc, Dept Med Chem, Dorval, PQ H9R 4P8, Canada

[2] Merck Res Labs, Rahway, NJ 07065 USA

[3] Merck Frosst Canada Inc, Dept Biochem, Dorval, PQ H9R 4P8, Canada

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 234卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

428-MEDI

引用

页数：1

共 50 条

[1] Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold
Beaulieu, Christian
Guay, Daniel
Wang, Zhaoyin
Leblanc, Yves
Roy, Patrick
Dufresne, Claude
Zamboni, Robert
Berthelette, Carl
Day, Stephen
Tsou, Nancy
Denis, Danielle
Greig, Gillian
Mathieu, Marie-Claude
O'Neill, Gary
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (08) : 2696 - 2700
[2] Asymmetric synthesis of a prostaglandin D2 receptor antagonist
Campos, KR
Journet, M
Lee, S
Grabowski, EJJ
Tillyer, RD
JOURNAL OF ORGANIC CHEMISTRY, 2005, 70 (01): : 268 - 274
[3] Development of prostaglandin D2 receptor antagonist:: discovery of highly potent antagonists
Torisu, K
Kobayashi, K
Iwahashi, M
Nakai, Y
Onoda, T
Nagase, T
Sugimoto, I
Okada, Y
Matsumoto, R
Nanbu, F
Ohuchida, S
Nakai, H
Toda, M
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (17) : 4685 - 4700
[4] Development of a prostaglandin D2 receptor antagonist:: discovery of a new chemical lead
Torisu, K
Kobayashi, K
Iwahashi, M
Egashira, H
Nakai, Y
Okada, Y
Nanbu, F
Ohuchida, S
Nakai, H
Toda, M
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (05) : 505 - 519
[5] Discovery of selective indole-based prostaglandin D2 receptor antagonist
Iwahashi, Maki
Shimabukuro, Atsushi
Onoda, Takahiro
Matsunaga, Yoko
Okada, Yutaka
Matsumoto, Ryoji
Nambu, Fumio
Nakai, Hisao
Toda, Masaaki
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4574 - 4588
[6] Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist
Lai, E.
Wenning, L. A.
Crumley, T. M.
De Lepeleire, I.
Liu, F.
de Hoon, J. N.
Van Hecken, A.
Depre, M.
Hilliard, D.
Greenberg, H.
O'Neill, G.
Metters, K.
Gottesdiener, K. G.
Wagner, J. A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 840 - 847
[7] A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep
Shichijo, M.
Arimura, A.
Hirano, Y.
Yasui, K.
Suzuki, N.
Deguchi, M.
Abraham, W. M.
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (09): : 1404 - 1414
[8] Identification and characterization of a potent and selective antagonist of the prostaglandin D2 receptor
Eberhardt, Christine
Wright, Dale
Gomez, Anna
Cook, Adam
Doherty, George
Corrette, Christopher
Hunt, Kevin
Clark, Christopher
Kim, Ganghyeok
Romoff, Todd
Delisle, Kirk
Hayter, Laura
Neale, Jason
Dean, Brian
Chantry, David
Carter, Laura
Burgess, Laurence E.
JOURNAL OF IMMUNOLOGY, 2009, 182
[9] The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant
Brightling, Chris
Kulkarni, Swarupa
Lambrecht, Bart N.
Sandham, David
Weiss, Markus
Altman, Pablo
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 68
[10] Metabolic activation of an indole-containing prostaglandin D2 receptor antagonist
Levesque, Jean-Francois
Day, Stephen
Chauret, Nathalie
Seto, Carmai
Trimble, Laird
Bateman, Kevin
Berthelette, Carl
Lachance, Nicolas
Sturino, Claudio
Nicoll-Griffith, Deborah
DRUG METABOLISM REVIEWS, 2006, 38 : 176 - 176

← 1 2 3 4 5 →